PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11439219-0	2001	Phenobarbitone-induced liver response in wild type and in p53 deficient mice.	Phenobarbital	0-14	transformation related protein 53, pseudogene	Mus musculus	58-61	
11311572-3	2001	We have investigated the effect of p53 on sodium phenobarbitone (PB)-induced liver proliferation and polyploidisation.	Phenobarbital	42-63	transformation related protein 53, pseudogene	Mus musculus	35-38	
9751125-6	1998	Phenobarbital inhibited both TGF-beta and bleomycin-induced apoptosis and the normal regulation of p53, bcl-2, and bax.	Phenobarbital	0-13	transformation related protein 53, pseudogene	Mus musculus	99-102	
9683175-9	1998	A reduction in p53 protein, but not transcript levels, was observed in hepatocytes exposed to PB.	Phenobarbital	94-96	transformation related protein 53, pseudogene	Mus musculus	15-18	
9683175-10	1998	Additionally, PB delayed and attenuated p53 protein induction during DNA damage, which suggests that changes in the p53 protein may be contributing to the attenuated G1 checkpoint response caused by PB.	Phenobarbital	14-16	transformation related protein 53, pseudogene	Mus musculus	40-43	
9683175-10	1998	Additionally, PB delayed and attenuated p53 protein induction during DNA damage, which suggests that changes in the p53 protein may be contributing to the attenuated G1 checkpoint response caused by PB.	Phenobarbital	14-16	transformation related protein 53, pseudogene	Mus musculus	116-119	
9683175-10	1998	Additionally, PB delayed and attenuated p53 protein induction during DNA damage, which suggests that changes in the p53 protein may be contributing to the attenuated G1 checkpoint response caused by PB.	Phenobarbital	199-201	transformation related protein 53, pseudogene	Mus musculus	116-119	
8142011-0	1994	Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone.	Phenobarbital	117-131	transformation related protein 53, pseudogene	Mus musculus	14-17	
34695137-15	2021	Significant associations were found between p53 overexpression and histological grade (p = 0.034), triple negative (p = 0.0333) and luminal B (p<0.01) tumors.	Phenobarbital	132-139	transformation related protein 53, pseudogene	Mus musculus	44-47	
10449034-7	1999	Phenobarbital, a potent liver tumor promoter, inhibited apoptosis in c-myc hepatocytes but not in wild-type hepatocytes, decreased p53 and bax, and increased bcl-2 protein levels.	Phenobarbital	0-13	transformation related protein 53, pseudogene	Mus musculus	131-134	
9715508-1	1998	The tumorigenic potential of phenobarbital was examined in a 26-wk carcinogenesis bioassay using p53 heterozygous mice and wild-type controls.	Phenobarbital	29-42	transformation related protein 53, pseudogene	Mus musculus	97-100	
9230198-5	1997	Dissociation of p53 proteins from degrading T antigens followed by a phenobarbital and c-myc-dependent, 15-fold induction of Bax protein, known to activate the apoptotic pathway downstream of p53, occurred in association with this phenomenon.	Phenobarbital	69-82	transformation related protein 53, pseudogene	Mus musculus	16-19	
9230198-5	1997	Dissociation of p53 proteins from degrading T antigens followed by a phenobarbital and c-myc-dependent, 15-fold induction of Bax protein, known to activate the apoptotic pathway downstream of p53, occurred in association with this phenomenon.	Phenobarbital	69-82	transformation related protein 53, pseudogene	Mus musculus	192-195	
33686070-4	2021	We found that perturbing Brca1/p53 in luminal progenitors induces aberrant alveolar differentiation pre-malignancy accompanied by pro-tumourigenic changes in the immune compartment.	Phenobarbital	38-45	transformation related protein 53, pseudogene	Mus musculus	31-34	
33686070-6	2021	Based on our data we propose a model where Brca1/p53 LOF inadvertently promotes a differentiation program hardwired in luminal progenitors, highlighting the deterministic role of the cell-of-origin and offering a potential explanation for the tissue specificity of BRCA1 tumours.	Phenobarbital	119-126	transformation related protein 53, pseudogene	Mus musculus	49-52